ExodusPoint Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-242,457
| Closed | -$3.79M | – | 1378 |
|
|
2025
Q1 | $3.79M | Buy |
+242,457
| New | +$3.79M | 0.04% | 467 |
|
|
2024
Q4 | – | Sell |
-323,701
| Closed | -$3.01M | – | 1374 |
|
|
2024
Q3 | $3.01M | Sell |
323,701
-789,881
| -71% | -$7.34M | 0.02% | 539 |
|
|
2024
Q2 | $10.4M | Buy |
1,113,582
+891,360
| +401% | +$8.29M | 0.07% | 212 |
|
|
2024
Q1 | $2.2M | Buy |
+222,222
| New | +$2.2M | 0.02% | 564 |
|
|
2023
Q4 | – | Sell |
-33,545
| Closed | -$178K | – | 1374 |
|
|
2023
Q3 | $178K | Buy |
+33,545
| New | +$178K | ﹤0.01% | 1495 |
|
|
2023
Q1 | – | Sell |
-65,995
| Closed | -$977K | – | 1637 |
|
|
2022
Q4 | $977K | Buy |
65,995
+18,940
| +40% | +$280K | 0.01% | 932 |
|
|
2022
Q3 | $899K | Buy |
+47,055
| New | +$899K | 0.01% | 1122 |
|